Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02353377 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OXINIUM◊ DH Total Hip Arthroplasty Pivotal Study

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: [Redacted] to Smith & Nephew, Inc.v21 Show 6 more changesShow less
    • Results first posted: Mar 19, 2026
    • Trial status: Withheld to Active, Not Recruiting
    • Primary completion date: Sep 21, 2021
    • Study completion date: Feb 7, 2030
    • Start date: Jan 2015
    • Study title shortened, about 6 words
  2. 19 versions Re-verified since Jan 30, 2015, no change to tracked fieldsv2-v20
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to monitor safety of the participants implanted with the OXINIUM◊ DH Hip System up to 10-years post-implantation
Trial Details
NCT Number NCT02353377
Lead Sponsor Smith & Nephew, Inc.
Conditions
(from sponsor)		 Hip Osteoarthritis
Related terms Hip Fractures, Osteoarthritis, Osteoarthritis, Hip, Osteonecrosis
Enrollment 413 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov